Castle biosciences to present new data at eado supporting the clinical value of the decisiondx®-melanoma test in guiding risk-aligned management of patients with melanoma

Castle will present data on decisiondx-melanoma at the 11th world congress of melanoma and 21st european association of dermato-oncology (eado) congress.

CSTL Ratings Summary

CSTL Quant Ranking